University of Minnesota. Driven to Discover.
Peramivir, made by BioCryst, is intended to be given to influenza patients in a single intravenous dose.
The 2 highly pathogenic strains in Washington state raise questions about possible connections with outbreaks in Canada and Europe.
The agencies warned that H5N8 represents a serious threat, especially to less-wealthy European nations.
The WHO has heightened concerns about the impact the outbreak is having on frontline workers and the prospects of overseas help.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.